|
Symbol
|
QQHRCH | LBBRDU | EFCCBL |
|---|---|---|---|
| Name | Worst of Reverse Convertible | Callable Multi Barrier Reverse Convertible | Barrier Reverse Convertible |
|
Underlying
|
AstraZeneca / GlaxoSmithKline / Sanofi-Aventis | AstraZeneca Plc. / BioNTech SE / Novartis AG | AstraZeneca Plc. / Eli Lilly & Co. / Merck & Co. Inc. / Sandoz Group AG |
|
Issuer
|
|
|
|
|
Date of maturity
|
30.12.2026 | 08.04.2027 | 01.07.2027 |
| Bid | 98.21 | - | 95.52 |
| Ask | 99.01 | - | 96.32 |